Health Canada Approves Illuccix® for Prostate Cancer Imaging

Go back to Health Canada Approves Illuccix® for Prostate Cancer Imaging
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 9.51 +0.25 (2.70%)
Previous Close $9.26    52 Week High $2.18 
Open $9.55    52 Week Low $0.30 
Day High $9.60    P/E N/A 
Day Low $9.48    EPS $-3.32 
Volume 211,313